Haedefenz

Class [005]
Pharmaceutical preparations, namely, blood plasma, blood plasma fractions, protein arrays for medical diagnosis purposes, stem cells for veterinary purposes, stem cells for medical purposes, blood culture media for medical and veterinary purposes, and blood for medical purposes; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of hereditary angioedema (HAE); pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of acute respiratory distress syndrome (ARDS); pharmaceutical preparations for the treatment of idiopathic pulmonary fibrosis (IPF); pharmaceutical preparations for the treatment of interstitial lung disease (ILD); pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, influenza and respiratory diseases and disorders; antibodies for medical use, namely, pharmaceutical antibodies for the treatment of hereditary angioedema (HAE), respiratory diseases and respiratory syndromes, for auto-immune diseases, and for the prevention and treatment of auto-immune diseases; antibodies for medical use, namely, pharmaceutical antibodies for the treatment of acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), and interstitial lung disease (ILD); antibodies for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, namely COVID-19, coronavirus disease, influenza and respiratory diseases and disorders.